![](https://usercontent.one/wp/medimix.be/wp-content/uploads/sites/3/2024/05/eps012-alina-1024x576.png)
Episode 12: Alectinib massively improves DFS in early stage ALK+ NSCLC patients: the ALINA trial
In this episode of WND focusing on lung cancer, Prof Johan Vansteenkiste from University Hospitals Leuven and Prof Mariana Brandao, a medical oncologist at Institut Jules Bordet in Brussels, delve into the ALINA trial, which investigates the use of alectinib